Evidence map›Paper›PMID 25775599›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

ORMDL orosomucoid-like proteins are degraded by free-cholesterol-loading-induced autophagy.

Shuhui Wang, Peggy Robinet, Jonathan D Smith, Kailash Gulshan

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. ORMDL Proteins Turnover via Proteasome and Autophagy Is Cell-Type Dependent and Tied to Ceramide Homeostasis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. ORMDL in metabolic health and disease.Pharmacology & therapeutics · 2023
    Review
  10. Article
  11. Article
  12. Sphingolipids and Asthma.Advances in experimental medicine and biology · 2022
    Article
  13. Article
  14. Article
  15. Interplay Between Lipid Metabolism and Autophagy.Frontiers in cell and developmental biology · 2020
    Review
  16. ORMDL3 and allergic asthma: From physiology to pathology.The Journal of allergy and clinical immunology · 2019
    Review
  17. Article
  18. Article
  19. Article
  20. Associations ofArchives animal breeding · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Shuhui WangDepartments of Cellular and Molecular Medicine and.
Peggy RobinetDepartments of Cellular and Molecular Medicine and.
Jonathan D SmithDepartments of Cellular and Molecular Medicine and Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH 44195 gulshak@ccf.org smithj4@ccf.org.
Kailash GulshanDepartments of Cellular and Molecular Medicine and gulshak@ccf.org smithj4@ccf.org.
Cleveland Clinic · US

Funding

Vascular Cell function and AtherosclerosisP01HL029582 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI FOX, PAUL L · 1985 to 2019
$32.0M
Regression of Atherosclerosis CoreP01HL098055 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI FISHER, EDWARD A · 2010 to 2014
$12.1M
NHLBI NIH HHS P01 HL029582NHLBI NIH HHS P01 HL098055
6 · The paper itself

Abstract

Eukaryotic cells have evolved robust mechanisms to counter excess cholesterol including redistribution of lipids into different compartments and compensatory up-regulation of phospholipid biosynthesis. We demonstrate here that excess cellular cholesterol increased the activity of the endoplasmic reticulum (ER) enzyme serine palmitoyl-CoA transferase (SPT), the rate-limiting enzyme in sphingomyelin synthesis. This increased SPT activity was not due to altered levels of SPTLC1 or SPTLC2, the major subunits of SPT. Instead, cholesterol loading decreased the levels of ORMDL1, a negative regulator of SPT activity, due to its increased turnover. Several lines of evidence demonstrated that free-cholesterol-induced autophagy, which led to increased turnover of ORMDL1. Cholesterol loading induced ORMDL1 redistribution from the ER to cytoplasmic p62 positive autophagosomes. Coimmunoprecipitation analysis of cholesterol-loaded cells showed increased association between ORMDL1 and p62. The lysosomal inhibitor chloroquine or siRNA knockdown of Atg7 inhibited ORMDL1 degradation by cholesterol, whereas proteasome inhibitors showed no effect. ORMDL1 degradation was specific to free-cholesterol loading as autophagy induced by serum starvation or general ER stress did not lead to ORMDL1 degradation. ORMDL proteins are thus previously unidentified responders to excess cholesterol, exiting the ER to activate SPT and increase sphingomyelin biosynthesis, which may buffer excess cellular cholesterol.

Indexed as

AutophagyAnimalsAsthmaAtherosclerosisBiological TransportCell LineCholesterolCycloheximideEndoplasmic ReticulumEndoplasmic Reticulum StressEosinophilsHomeostasisLipidsMacrophagesMembrane MicrodomainsMembrane ProteinsCholesterolCycloheximideLipidsMembrane ProteinsORMDL1 protein, mouseOrosomucoidSerine C-PalmitoyltransferaseSphingolipidsSphingomyelinsautophagyfree cholesterolORMDL1serine palmitoyl-CoA transferasesphingomyelin

Identifiers

PMID25775599
PMCPMC4378419
OpenAlexW1964294139

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.